SNOA
Sonoma Pharmaceuticals, Inc.
Key Financials
Operating Income
$-3710000
↑ 21.1%
Net Income
$-3457000
↑ 28.5%
Gross Profit
$5.5M
↑ 15.2%
Revenue
$14.3M
↑ 12.2%
EPS (Diluted)
$-2.79
↓ 426.4%
Shareholders' Equity
$4.4M
↓ 28.1%
Total Assets
$13.7M
↓ 7.1%
Cash & Equivalents
$5.4M
↑ 71.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| S-1 | 4/17/2026 | View on SEC |
| DRS | 4/9/2026 | View on SEC |
| 8-K | 4/9/2026 | View on SEC |
| 10-Q | 2/10/2026 | View on SEC |
| 3 | 2/9/2026 | View on SEC |
| 8-K | 1/28/2026 | View on SEC |
| 8-K | 1/12/2026 | View on SEC |
| 4 | 1/2/2026 | View on SEC |
| 4 | 1/2/2026 | View on SEC |
| 4 | 1/2/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SNOA |
| Company Name | Sonoma Pharmaceuticals, Inc. |
| CIK | 1367083 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 0331 |
| State of Incorporation | DE |
| Phone | 800-759-9305 |